for the 3rd Quarter of 2017 Ending 30 September 2017 To : The President The Stock Exchange of Thailand The Board of Directors meeting of Ratchaphruek Hospital Public Company Limited (the Company) No. 5

: Management explanation and analysis for three-month period ended September 30, 2017 Attention : The President of, The Stock Exchange of Thailand ZIGA Innovation Public Company Limited (“the Company”) would

October 11, 2019 Re: Clarification of the operating results of company and its subsidiaries for the nine month periods ended September 30, 2018 To: President The Stock Exchange of Thailand K.C

Bt23,480mn (OCF less CAPEX, spectrum license, and lease liability paid). In summary, net cash increased by Bt5,730mn resulting in an outstanding cash of Bt14,744mn at the end of Dec-23. Net FX gain at Bt620mn

\(Microsoft Word - 26 \\340\\301.\\302.61_Eng_.doc\) April 26, 2018 To : Managing Director The Stock Exchange of Thailand Re : The acquisition of investment in Buriram Ruampaet Co.,Ltd. The board of

Ref. No. 1711/056EN November 8, 2017 Subject Management Discussion and Analysis for Q3/2017 (Ending September 30, 2017) To Director and Manager of the Stock Exchange of Thailand Ubis (Asia) Public

December 31, 2017) To Director and Manager of the Stock Exchange of Thailand Ubis (Asia) Public Company Limited (“the Company”) would like to clarify on the performance and the financial status for the year

Ref. No. 1802/008EN February 20, 2018 Subject Management Discussion and Analysis for the year 2017 (Ending December 31, 2017) (Additional) To Director and Manager of the Stock Exchange of Thailand

(Translation) Ref. No. 1808/036EN August 10, 2018 Subject: Operating Result Clarification for Q2/2018 (Ending June 30, 2018) To: Director and Manager of the Stock Exchange of Thailand Ubis (Asia

\(Microsoft Word - 16 \\312\\244 61_Eng_.doc\) August 16th, 2018 To : Managing Director The Stock Exchange of Thailand Re : The acquisition of investment in Muengloei-Ram Co.,Ltd.(s remainder and new